Skip to main content
Erschienen in: Urolithiasis 5/2013

01.10.2013 | Original Paper

Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy

verfasst von: Tunc Erdil, Yakup Bostanci, Ender Ozden, Fatih Atac, Yarkin Kamil Yakupoglu, Ali Faik Yilmaz, Saban Sarikaya

Erschienen in: Urolithiasis | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to analyze the pre- and intraoperative risk factors that affect the development of postoperative systemic inflammatory response syndrome (SIRS) after percutaneous nephrolithotomy (PCNL). Medical records on 317 adult patients with the complete data who underwent single-stage PCNL and followed at our center were retrospectively studied. Patients’ data were collected through a database which was collected prospectively. All patients’ vital signs were recorded hourly in the postoperative period and were divided into two groups as patients developing SIRS and not developing SIRS. There were 202 men and 115 women with a mean age of 48 ± 13.7 (range 19–82) years. There were 53 (16.7 %) in the SIRS and 264 (83.3 %) patients in the non-SIRS group. Preoperative positive urine cultures (UCs), intraoperative positive renal pelvic urine cultures (RPUCs), and stone cultures (SCs) were strongly correlated with the development of SIRS (p = 0.001). In the SIRS developers’ group, preoperative UCs, intraoperative RPUCs, and SCs were positive in 33.9, 22.5, and 28.6 % of patients, respectively, but only 9.8, 3.3, and 4.2 % for the corresponding specimens in non-SIRS group. Positive preoperative UCs, intraoperative RPUCs, and SCs are important factors indicating the development of postoperative SIRS. Appropriately treated preoperative urinary infections may not prevent infected urine at PCNL. RPUCs and SCs may be the only way to identify the causative organism and direct antimicrobial therapy, so we recommend collecting RPUCs and SCs routinely to identify the offending organism and guide treatment.
Literatur
1.
Zurück zum Zitat Resorlu B, Kara C, Oguz U, Bayindir M, Unsal A (2011) Percutaneous nephrolithotomy for complex caliceal and staghorn stones in patients with solitary kidney. Urol Res 39:171–176PubMedCrossRef Resorlu B, Kara C, Oguz U, Bayindir M, Unsal A (2011) Percutaneous nephrolithotomy for complex caliceal and staghorn stones in patients with solitary kidney. Urol Res 39:171–176PubMedCrossRef
2.
Zurück zum Zitat Zhong W, Zeng G, Wu W, Chen W, Wu K (2011) Minimally invasive percutaneous nephrolithotomy with multiple mini tracts in a single session in treating staghorn calculi. Urol Res 39:117–122PubMedCrossRef Zhong W, Zeng G, Wu W, Chen W, Wu K (2011) Minimally invasive percutaneous nephrolithotomy with multiple mini tracts in a single session in treating staghorn calculi. Urol Res 39:117–122PubMedCrossRef
3.
Zurück zum Zitat Ozden E, Mercimek MN, Bostanci Y, Yakupoglu YK, Sirtbas A, Sarikaya S (2012) Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology 79:990–994PubMedCrossRef Ozden E, Mercimek MN, Bostanci Y, Yakupoglu YK, Sirtbas A, Sarikaya S (2012) Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology 79:990–994PubMedCrossRef
4.
Zurück zum Zitat Dogan HS, Guliyev F, Cetinkaya YS, Sofikerim M, Ozden E, Sahin A (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39:737–742PubMedCrossRef Dogan HS, Guliyev F, Cetinkaya YS, Sofikerim M, Ozden E, Sahin A (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39:737–742PubMedCrossRef
5.
Zurück zum Zitat Lojanapiwat B, Kitirattrakarn P (2011) Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int 86:448–452PubMedCrossRef Lojanapiwat B, Kitirattrakarn P (2011) Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int 86:448–452PubMedCrossRef
6.
Zurück zum Zitat Chen L, Xu QQ, Li JX, Xiong LL, Wang XF, Huang XB (2008) Systemic inflammatory response syndrome after percutaneous nephrolithotomy: an assessment of risk factors. Int J Urol 15:1025–1028PubMedCrossRef Chen L, Xu QQ, Li JX, Xiong LL, Wang XF, Huang XB (2008) Systemic inflammatory response syndrome after percutaneous nephrolithotomy: an assessment of risk factors. Int J Urol 15:1025–1028PubMedCrossRef
7.
Zurück zum Zitat O’Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN (1993) Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 72:277–283PubMed O’Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN (1993) Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 72:277–283PubMed
8.
Zurück zum Zitat Charton M, Vallancien G, Veillon B, Brisset JM (1986) Urinary tract infection in percutaneous surgery for renal calculi. J Urol 135:15–17PubMed Charton M, Vallancien G, Veillon B, Brisset JM (1986) Urinary tract infection in percutaneous surgery for renal calculi. J Urol 135:15–17PubMed
9.
Zurück zum Zitat Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955–960PubMed Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955–960PubMed
10.
Zurück zum Zitat Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef
11.
Zurück zum Zitat Korets R, Graversen JA, Kates M, Mues AC, Gupta M (2011) Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol 186:1899–1903PubMedCrossRef Korets R, Graversen JA, Kates M, Mues AC, Gupta M (2011) Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol 186:1899–1903PubMedCrossRef
12.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256PubMedCrossRef Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256PubMedCrossRef
13.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef
14.
Zurück zum Zitat Draga RO, Kok ET, Sorel MR, Bosch RJ, Lock TM (2009) Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol 23:921–927PubMedCrossRef Draga RO, Kok ET, Sorel MR, Bosch RJ, Lock TM (2009) Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol 23:921–927PubMedCrossRef
15.
Zurück zum Zitat Mariappan P, Smith G, Moussa SA, Tolley DA (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98:1075–1079PubMedCrossRef Mariappan P, Smith G, Moussa SA, Tolley DA (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98:1075–1079PubMedCrossRef
16.
Zurück zum Zitat Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA (2006) Clinical implication of routine stone culture in percutaneous nephrolithotomy: a prospective study. Urology 67:26–29PubMedCrossRef Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA (2006) Clinical implication of routine stone culture in percutaneous nephrolithotomy: a prospective study. Urology 67:26–29PubMedCrossRef
17.
Zurück zum Zitat Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610–1614PubMedCrossRef Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610–1614PubMedCrossRef
18.
Zurück zum Zitat Sharifi Aghdas F, Akhavizadegan H, Aryanpoor A, Inanloo H, Karbakhsh M (2006) Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect (Larchmt) 7:367–371CrossRef Sharifi Aghdas F, Akhavizadegan H, Aryanpoor A, Inanloo H, Karbakhsh M (2006) Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect (Larchmt) 7:367–371CrossRef
19.
Zurück zum Zitat Gonen M, Turan H, Ozturk B, Ozkardes H (2008) Factors affecting fever following percutaneous nephrolithotomy: a prospective clinical study. J Endourol 22:2135–2138PubMedCrossRef Gonen M, Turan H, Ozturk B, Ozkardes H (2008) Factors affecting fever following percutaneous nephrolithotomy: a prospective clinical study. J Endourol 22:2135–2138PubMedCrossRef
20.
Zurück zum Zitat Aron M, Goel R, Gupta NP, Seth A (2005) Incidental detection of purulent fluid in kidney at percutaneous nephrolithotomy for branched renal calculi. J Endourol 19:136–139PubMedCrossRef Aron M, Goel R, Gupta NP, Seth A (2005) Incidental detection of purulent fluid in kidney at percutaneous nephrolithotomy for branched renal calculi. J Endourol 19:136–139PubMedCrossRef
21.
Zurück zum Zitat Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S (2002) Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 16:649–653PubMedCrossRef Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S (2002) Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 16:649–653PubMedCrossRef
22.
Zurück zum Zitat Vorrakitpokatorn P, Permtongchuchai K, Raksamani EO, Phettongkam A (2006) Perioperative complications and risk factors of percutaneous nephrolithotomy. J Med Assoc Thai 89:826–833PubMed Vorrakitpokatorn P, Permtongchuchai K, Raksamani EO, Phettongkam A (2006) Perioperative complications and risk factors of percutaneous nephrolithotomy. J Med Assoc Thai 89:826–833PubMed
23.
Zurück zum Zitat Bratell S, Brorson JE, Grenabo L, Hedelin H, Pettersson S (1990) The bacteriology of operated renal stones. Eur Urol 17:58–61PubMed Bratell S, Brorson JE, Grenabo L, Hedelin H, Pettersson S (1990) The bacteriology of operated renal stones. Eur Urol 17:58–61PubMed
24.
Zurück zum Zitat Mariappan P, Loong CW (2004) Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol 171:2142–2145PubMedCrossRef Mariappan P, Loong CW (2004) Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol 171:2142–2145PubMedCrossRef
25.
Zurück zum Zitat Ziaee SA, Kazemi B, Moghaddam SM et al (2008) A study of febrile versus afebrile patients after percutaneous nephrolithotomy regarding bacterial etiologic factors through blood and urine cultures and 16S rRNA detection in serum. J Endourol 22:2717–2721PubMedCrossRef Ziaee SA, Kazemi B, Moghaddam SM et al (2008) A study of febrile versus afebrile patients after percutaneous nephrolithotomy regarding bacterial etiologic factors through blood and urine cultures and 16S rRNA detection in serum. J Endourol 22:2717–2721PubMedCrossRef
26.
Zurück zum Zitat Cadeddu JA, Chen R, Bishoff J et al (1998) Clinical significance of fever after percutaneous nephrolithotomy. Urology 52:48–50PubMedCrossRef Cadeddu JA, Chen R, Bishoff J et al (1998) Clinical significance of fever after percutaneous nephrolithotomy. Urology 52:48–50PubMedCrossRef
27.
Zurück zum Zitat Opal SM, Scannon PJ, Vincent JL et al (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–1589PubMedCrossRef Opal SM, Scannon PJ, Vincent JL et al (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–1589PubMedCrossRef
28.
Zurück zum Zitat Kumar S, Bag S, Ganesamoni R, Mandal AK, Taneja N, Singh SK (2012) Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis. Urol Res 40:79–86PubMedCrossRef Kumar S, Bag S, Ganesamoni R, Mandal AK, Taneja N, Singh SK (2012) Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis. Urol Res 40:79–86PubMedCrossRef
29.
Zurück zum Zitat Thomas LL, Sturk A, Buller HR, ten Cate JW, Spijker RE, ten Cate H (1984) Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am J Clin Pathol 82:203–206PubMed Thomas LL, Sturk A, Buller HR, ten Cate JW, Spijker RE, ten Cate H (1984) Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am J Clin Pathol 82:203–206PubMed
Metadaten
Titel
Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy
verfasst von
Tunc Erdil
Yakup Bostanci
Ender Ozden
Fatih Atac
Yarkin Kamil Yakupoglu
Ali Faik Yilmaz
Saban Sarikaya
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 5/2013
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0570-y

Weitere Artikel der Ausgabe 5/2013

Urolithiasis 5/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.